Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/Regen Biopharma, Inc./ 10-Q

Quarterly Report · 10-Q

Regen Biopharma, Inc.

RGBPOTCEQUITYCurrent

Quarterly Report

Filed May 14, 2026Accepted May 14, 2026, 12:17 PM EDTCIK 1589150Accession 0001493152-26-022924
View company →Permanent SEC source ↗
Share

Company context

Current securities

RGBPOTC · EQUITY · CurrentRGBPPOTC · PREFERRED · Current

Recent company filings

  1. 10-Q filingAug 17, 2026
  2. NT 10-Q filingAug 13, 2026
  3. Entry into a Material Definitive Agreement · Changes in Registrant's Certifying Accountant · Other EventsJul 15, 2026
  4. Unregistered Sales of Equity SecuritiesMar 4, 2026
  5. 10-Q filingFeb 13, 2026

As-filed source

Primary evidence
As filedOpen full document ↗